Preferred Label : PD-L1 Positive;

NCIt synonyms : PDCD1L1 Positive; CD274 Antigen Positive; Expression of PD-L1; PDL1 Positive; CD274 Molecule Positive; B7-H Positive; PD-L1 ; B7 Homolog 1 Positive; Programmed Cell Death 1 Ligand 1 Positive; B7H1 Positive; PDCD1LG1 Positive; CD274 Positive;

NCIt related terms : Positive;

NCIt definition : An immunohistochemical test result that indicates expression of PD-L1 in a tissue sample of a primary or metastatic malignant neoplasm.;

NCI Metathesaurus CUI : CL508921;

Details


Keyword's position in hierarchy(ies) : arborescence

Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3470178/fr/acces-precoce-des-medicaments-un-bilan-positif-apres-deux-ans-de-mise-en-place-du-dispositif
2023
France
technical report
technical report
devices
devices
GNAQ Gene Mutation
GNAQ Gene Mutation
MGMT Gene Promoter Methylation
MGMT Gene Promoter Methylation
Positive Lymph Node
Positive Lymph Node
ATRX Gene Mutation
ATRX Gene Mutation
During or After
During or After
PAS Positive
PAS Positive
GDC Therapeutic Agent Terminology
GDC Therapeutic Agent Terminology
BAP1 Gene Mutation
BAP1 Gene Mutation
NRAS Gene Mutation
NRAS Gene Mutation
pharmaceutical preparations
pharmaceutical preparations
Status Post
Status Post
ETV Gene Rearrangement
ETV Gene Rearrangement
Hepatitis C Virus RNA Positive
Hepatitis C Virus RNA Positive
GNA11 Gene Mutation
GNA11 Gene Mutation
Entrapment of Device
Entrapment of Device
SDHA Positive
SDHA Positive
HRAS Gene Mutation
HRAS Gene Mutation
ESR2 Positive
ESR2 Positive
device, nos
device, nos
ERBB2 Gene Amplification
ERBB2 Gene Amplification
TERT Promoter Mutation
TERT Promoter Mutation
PAX8 Gene Rearrangement
PAX8 Gene Rearrangement
One to Two Years
One to Two Years
SDHB Positive
SDHB Positive
ERBB2 Gene Mutation
ERBB2 Gene Mutation
Positive Number
Positive Number
Checkup
Checkup
RET/PTC Rearrangement
RET/PTC Rearrangement
Progesterone Receptor Positive
Progesterone Receptor Positive
ERG Gene Rearrangement
ERG Gene Rearrangement
FGFR3 Gene Mutation
FGFR3 Gene Mutation
FGFR2 Gene Mutation
FGFR2 Gene Mutation
Set, Psychology
Set, Psychology
KIT Positive
KIT Positive
FGFR1 Gene Rearrangement
FGFR1 Gene Rearrangement
drug, nos
drug, nos
Hepatitis B Surface Antibody Positive
Hepatitis B Surface Antibody Positive
CDH1 Gene Mutation
CDH1 Gene Mutation
Balance Sheet
Balance Sheet
equipment and supplies
equipment and supplies
1p/19q Codeletion
1p/19q Codeletion
Hepatitis B DNA Positive
Hepatitis B DNA Positive
Estrogen Receptor Positive
Estrogen Receptor Positive
ANO1 Positive
ANO1 Positive
c-MET Gene Amplification
c-MET Gene Amplification
Positive EBV Test
Positive EBV Test
FGFR3 Gene Rearrangement
FGFR3 Gene Rearrangement
FGFR2 Gene Rearrangement
FGFR2 Gene Rearrangement
IDH Gene Family Mutation
IDH Gene Family Mutation
Hepatitis B Virus Surface Antigen Positive
Hepatitis B Virus Surface Antigen Positive
PD-L1 Positive
PD-L1 Positive
Human Immunodeficiency Virus Positive
Human Immunodeficiency Virus Positive
Pharmacologic Substance
Pharmacologic Substance
CTNNB1 Gene Mutation
CTNNB1 Gene Mutation
KRAS Gene Mutation
KRAS Gene Mutation

---
https://pgtmsite.files.wordpress.com/2024/01/pertuzumab_position-preliminaire_final.pdf
2014
Canada
drug information
drug information
PAX8 Gene Rearrangement
PAX8 Gene Rearrangement
KIT Positive
KIT Positive
pertuzumab
pertuzumab
NRAS Gene Mutation
NRAS Gene Mutation
SDHB Positive
SDHB Positive
c-MET Gene Amplification
c-MET Gene Amplification
KRAS Gene Mutation
KRAS Gene Mutation
IDH Gene Family Mutation
IDH Gene Family Mutation
Hepatitis C Virus RNA Positive
Hepatitis C Virus RNA Positive
PAS Positive
PAS Positive
FGFR2 Gene Rearrangement
FGFR2 Gene Rearrangement
Positive Number
Positive Number
Estrogen Receptor Positive
Estrogen Receptor Positive
ANO1 Positive
ANO1 Positive
breast cancer
breast cancer
GNAQ Gene Mutation
GNAQ Gene Mutation
FGFR1 Gene Rearrangement
FGFR1 Gene Rearrangement
pertuzumab
pertuzumab
Human Immunodeficiency Virus Positive
Human Immunodeficiency Virus Positive
1p/19q Codeletion
1p/19q Codeletion
HER-2 positive breast cancer
HER-2 positive breast cancer
ESR2 Positive
ESR2 Positive
Hepatitis B Virus Surface Antigen Positive
Hepatitis B Virus Surface Antigen Positive
HRAS Gene Mutation
HRAS Gene Mutation
Breast Cancer Therapeutic Procedure
Breast Cancer Therapeutic Procedure
Herero Language
Herero Language
Positive Lymph Node
Positive Lymph Node
Positive EBV Test
Positive EBV Test
RET/PTC Rearrangement
RET/PTC Rearrangement
FGFR3 Gene Mutation
FGFR3 Gene Mutation
SDHA Positive
SDHA Positive
TERT Promoter Mutation
TERT Promoter Mutation
Pertuzumab
Pertuzumab
MGMT Gene Promoter Methylation
MGMT Gene Promoter Methylation
ERG Gene Rearrangement
ERG Gene Rearrangement
GNA11 Gene Mutation
GNA11 Gene Mutation
Metastatic Malignant Neoplasm in the Breast
Metastatic Malignant Neoplasm in the Breast
breast neoplasms
breast neoplasms
pertuzumab
pertuzumab
ATRX Gene Mutation
ATRX Gene Mutation
ERBB2 Gene Mutation
ERBB2 Gene Mutation
neoplasm, malignant
neoplasm, malignant
Hepatitis B DNA Positive
Hepatitis B DNA Positive
Hepatitis B Surface Antibody Positive
Hepatitis B Surface Antibody Positive
FGFR3 Gene Rearrangement
FGFR3 Gene Rearrangement
BAP1 Gene Mutation
BAP1 Gene Mutation
FGFR2 Gene Mutation
FGFR2 Gene Mutation
PD-L1 Positive
PD-L1 Positive
ERBB2 Gene Amplification
ERBB2 Gene Amplification
CDH1 Gene Mutation
CDH1 Gene Mutation
CTNNB1 Gene Mutation
CTNNB1 Gene Mutation
ETV Gene Rearrangement
ETV Gene Rearrangement
Progesterone Receptor Positive
Progesterone Receptor Positive

---
Nous contacter.
08/11/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.